Allegra-d Allergy And Congestion Tablet, Film Coated, Extended Release
Product Images NDC 41167-4310

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allegra-d Allergy And Congestion (NDC 41167-4310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 41167-4310-6allegra-d®allergy &congestion 12hrfexofenadine Hci 60 mg/antihistaminepseudoephedrine Hci 120 mg/nasal Decongestantextended Release Tablets30 Tablets (Allegra D Allergy And Congestion 12 Hr 01)

Ndc 41167-4310-6allegra-d®allergy &congestion 12hrfexofenadine Hci 60 mg/antihistaminepseudoephedrine Hci 120 mg/nasal Decongestantextended Release Tablets30 Tablets (Allegra D Allergy And Congestion 12 Hr 01)
Altegra-D is a medication that contains 60 mg of fexofenadine hydrochloride, an antihistamine, and 120 mg of pseudoephedrine hydrochloride, a nasal decongestant. It is used for indoor and outdoor relief of allergy symptoms. The remaining characters do not form any coherent meaningful text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.